Rising cancer cases are expected to Propel the Growth of the Global Integrin Beta Market.

Published: Mar 2022

The global integrin beta market is anticipated to grow at a considerable CAGR of around 6.5%during the forecast years. The increase in cancer cases all over the globe is driving the integrin beta market due to its increase the demand for integrin beta is also been increasing. For instance, As per the data released by International Agency for Research on Cancer (IARC), in 2018, there were 17.0 million new cancer cases and 9.5 million cancer deaths across the globe. The global burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. For instance, according to the American Cancer Society, in 2021, 1,898,160 new cancer cases and 608,570 cancer deaths are expected to occur in the United States. In contrast, by 2020, an estimated 1,806,590 young people were diagnosed with cancer in the United States, and 606,520 people died from the disease. 

Browse the full report description of “Global Integrin Beta Market Size, Share and Trends Analysis Report, By Type (IGBT1, IGBT2, IGBT3, IGBT4, IGBT5, IGBT6, IGBT7, and IGBT8), By Application (Genetic Disorder, CVD, Cancer, and Others), Forecast (2022-2028)” at https://www.omrglobal.com/industry-reports/integrin-beta-market

In February 2020, According to a report published by World Health Organization (WHO), Cancer is a leading cause of death across the globe, nearly 10 million deaths in 2020 were observed. Moreover, approximately 400 000 children develop cancer each year. The most common cancers are breast, lung, colon and rectum, and prostate cancers. Integrin beta combines with different ? subunits, including ?4, ?5, and ?2, to affect the characteristics of cancer cells, and the progression of tumors, and its primary function is to form focal adhesion between cancer cells and ECM owing to such factors the cell mutation can be stopped with integrin beta that in turn is augmenting the market to grow.

Market Coverage

  • The market number available for – 2022-2028
  • Base year- 2021
  • Forecast period- 2022-2028

Segment Covered- 

  • By Type
  • By Application

Regions Covered-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape- AstraZeneca, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Novartis International AG, Pfizer Inc., and Others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Integrin Beta Market Report Segment

By Type

  • IGBT 1 
  • IGBT 2
  • IGBT 3
  • IGBT 4
  • IGBT 5 
  • IGBT 6
  • IGBT 7
  • IGBT 8

By Application

  • Genetic Disorder 
  • CVD 
  • Cancer
  • Others 

Global Integrin Beta Market Report by Region

North America

  • US
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa


To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/integrin-beta-market